Evidence map›Paper›PMID 36556981›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Changes in Body Weight, Body Composition, Phase Angle, and Resting Metabolic Rate in Male Patients with Stage IV Non-Small-Cell Lung Cancer Undergoing Therapy.

Paraskevi Detopoulou, Theodora Tsiouda, Maria Pilikidou, Foteini Palyvou, Eirini Tsekitsidi, Maria Mantzorou, Persefoni Pezirkianidou, Krystallia Kyrka, Spyridon Methenitis, Gavriela Voulgaridou and 6 more

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Body composition alterations in patients with lung cancer.American journal of physiology. Cell physiology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Paraskevi DetopoulouDepartment of Clinical Nutrition, General Hospital Korgialenio Benakio, 57889 Athens, Greece.ORCID 0000-0003-1723-9192
Theodora TsioudaPulmonary-Oncology Department, 'Theageneio' Cancer Hospital, 54639 Thessaloniki, Greece.
Maria PilikidouDepartment of Nutritional Sciences and Dietetics, International Hellenic University, 57001 Thessaloniki, Greece.ORCID 0000-0002-8519-489X
Foteini PalyvouDepartment of Nutritional Sciences and Dietetics, International Hellenic University, 57001 Thessaloniki, Greece.
Eirini TsekitsidiDepartment of Nutritional Sciences and Dietetics, International Hellenic University, 57001 Thessaloniki, Greece.ORCID 0000-0002-6535-485X
Maria MantzorouDepartment of Food Science and Nutrition, University of Aegean, 81100 Lemnos, Greece.ORCID 0000-0002-2535-2841
Persefoni PezirkianidouPulmonary-Oncology Department, 'Theageneio' Cancer Hospital, 54639 Thessaloniki, Greece.
Krystallia KyrkaPulmonary-Oncology Department, 'Theageneio' Cancer Hospital, 54639 Thessaloniki, Greece.
Spyridon MethenitisSports Performance Laboratory, School of Physical Education and Sports Science, National and Kapodistrian University of Athens, 57668 Athens, Greece.ORCID 0000-0003-4370-1395
Gavriela VoulgaridouDepartment of Nutritional Sciences and Dietetics, International Hellenic University, 57001 Thessaloniki, Greece.
Pavlos ZarogoulidisPulmonary Department, General Clinic Euromedica Private Hospital, 54645 Thessaloniki, Greece.ORCID 0000-0001-5119-2207
Rena OikonomidouHealth Center of Evosmos, 56224 Thessaloniki, Greece.
Dimitris MatthaiosOncology Department, General Hospital of Rhodes, 86775 Rhodes, Greece.
Κonstantinos PorpodisPulmonary Department, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece.ORCID 0000-0001-7215-2191
Dimitrios Giannakidis1st Department of Surgery, Attica General Hospital "Sismanogleio-Amalia Fleming", 15126 Athens, Greece.ORCID 0000-0002-8438-4050
Sousana K PapadopoulouDepartment of Nutritional Sciences and Dietetics, International Hellenic University, 57001 Thessaloniki, Greece.
International Hellenic University · GRTheageneio General Hospital · GRAristotle University of Thessaloniki · GRGeneral Hospital of Rhodes · GRHellenic Agency for Local Development and Local Government · GRNational and Kapodistrian University of Athens · GRSimanogleio-Amalia Fleming General Hospital · GRUniversity of Peloponnese · GRUniversity of the Aegean · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Cancer treatments can adversely influence body weight status, body composition, phase angle (PhA), and resting metabolic rate (RMR), which could possibly affect disease course. Τhe aim was to assess differences in body composition, PhA, RMR, and related parameters in non-small-cell lung cancer (NSCLC) patients after treatment. Methods: The sample consisted of 82 NSCLC (stage IV) male patients (chemotherapy (C) 15.7%; immunotherapy (I) 13.3%; C + I 25.3%; (C) + radiotherapy (R) 22.9 %; and other 15.5%). Body weight and body composition, PhA, RMR, oxygen consumption (VO2), ventilation rate, and diet were assessed at baseline and at 3 months after initiation of therapy. Results: Reductions in PhA, RMR, VO2, ventilation rate, and intracellular water were observed at follow up. Weight loss was evident for 45% of patients who also had a reduction in lean body mass. In the group under C, lean mass was reduced at follow up (55.3 ± 11.53 vs. 52.4 ± 12.6, p = 0.04) without significant weight changes. In subjects with a low adherence to the Mediterranean diet (MedDietScore < 30), RMR (1940 ± 485 vs. 1730 ± 338 Kcal, p = 0.001), VO2 (277.1 ± 70.2 vs. 247 ± 49.1 mL/min, p = 0.001), and ventilation rate (10.1 ± 2.28 vs. 9. ± 2 2.2 L/min, p = 0.03) were significantly reduced. The changes in body weight were positively related to % of change in fat mass (rho = 0.322, p = 0.003) and absolute lean mass change (rho = 0.534, p < 0.001) and negatively associated with % of change in total body water (rho = −0.314, p = 0.004) (Spearman correlation coefficients). Conclusions: In conclusion, cancer therapy related to reductions in PhA and RMR, while lean mass reduction may be related to the type of treatment. Our results emphasize the importance of a more holistic nutritional and body composition assessment beyond body weight, to better address patients’ needs in clinical practice.

Indexed as

Carcinoma, Non-Small-Cell LungDiet, MediterraneanLung NeoplasmsBasal MetabolismBody CompositionBody Mass IndexBody WeightHumansMalebody compositionchemotherapydietimmunotherapylung cancerMediterranean dietphase angleradiotherapy

Identifiers

PMID36556981
PMCPMC9784033
OpenAlexW4311522321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.